hu.MAP 3.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: huMAP3_10801.1
Complex Portal: CPX-14345
Confidence: Medium High  
ProteinsGenename | Protein Name | Uniprot Annotation Score | Links |
---|---|---|---|
AXIN2 | Axin-2 (Axin-like protein) (Axil) (Axis inhibition protein 2) (Conductin) | 5 | UniProt   NCBI |
GSKIP | GSK3B-interacting protein (GSKIP) (GSK3beta interaction protein) | 5 | UniProt   NCBI |
GSK3A | Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1) | 5 | UniProt   NCBI |
FRAT2 | GSK-3-binding protein FRAT2 (Frequently rearranged in advanced T-cell lymphomas 2) (FRAT-2) | 3 | UniProt   NCBI |
GSK3B | Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) | 5 | UniProt   NCBI |
FRAT1 | Proto-oncogene FRAT1 (Frequently rearranged in advanced T-cell lymphomas 1) (FRAT-1) | 5 | UniProt   NCBI |
RILPL2 | RILP-like protein 2 (Rab-interacting lysosomal protein-like 2) (p40phox-binding protein) | 5 | UniProt   NCBI |
AXIN1 | Axin-1 (Axis inhibition protein 1) (hAxin) | 5 | UniProt   NCBI |
Enrichments
Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
---|---|---|---|---|
  REAC:R-HSA-196299 | 1.86009193219e-08 | 0.5 | FRAT2 GSK3B AXIN1 FRAT1 | Beta-catenin phosphorylation cascade |
  WP:WP4258 | 2.63612217757e-08 | 0.625 | FRAT2 FRAT1 AXIN2 AXIN1 GSK3B | lncRNA in canonical Wnt signaling and colorectal cancer |
  GO:0060070 | 4.0843531464e-08 | 0.875 | GSKIP GSK3B GSK3A AXIN1 FRAT1 FRAT2 AXIN2 | canonical Wnt signaling pathway |
  KEGG:05224 | 1.24295110103e-07 | 0.625 | FRAT2 FRAT1 AXIN2 AXIN1 GSK3B | Breast cancer |
  KEGG:05226 | 1.45399109258e-07 | 0.625 | FRAT2 FRAT1 AXIN2 AXIN1 GSK3B | Gastric cancer |
  REAC:R-HSA-4641262 | 2.45161444024e-07 | 0.5 | FRAT2 GSK3B AXIN1 FRAT1 | Disassembly of the destruction complex and recruitment of AXIN to the membrane |
  KEGG:04310 | 2.88091676092e-07 | 0.625 | FRAT2 FRAT1 AXIN2 AXIN1 GSK3B | Wnt signaling pathway |
  WP:WP4262 | 2.89310891288e-07 | 0.625 | FRAT2 FRAT1 AXIN2 AXIN1 GSK3B | Breast cancer pathway |
  GO:0016055 | 3.82554552541e-07 | 0.875 | GSKIP GSK3B GSK3A AXIN1 FRAT1 FRAT2 AXIN2 | Wnt signaling pathway |
  KEGG:05225 | 3.86417821983e-07 | 0.625 | FRAT2 FRAT1 AXIN2 AXIN1 GSK3B | Hepatocellular carcinoma |
  GO:0198738 | 4.22240102813e-07 | 0.875 | GSKIP GSK3B GSK3A AXIN1 FRAT1 FRAT2 AXIN2 | cell-cell signaling by wnt |
  WP:WP363 | 4.96305994219e-07 | 0.5 | GSK3A GSK3B AXIN1 FRAT1 | Wnt signaling pathway |
  GO:0030877 | 6.06890408176e-07 | 0.5 | GSK3A AXIN2 AXIN1 GSK3B | beta-catenin destruction complex |
  GO:0060828 | 2.69496671429e-06 | 0.75 | GSKIP GSK3B GSK3A AXIN1 FRAT1 AXIN2 | regulation of canonical Wnt signaling pathway |
  WP:WP4872 | 3.56530254203e-06 | 0.375 | FRAT1 GSK3B AXIN1 | MAP3K1 role in promoting and blocking gonadal determination |
  WP:WP4336 | 3.80843066597e-06 | 0.5 | FRAT2 GSK3B AXIN1 FRAT1 | ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
  WP:WP2059 | 4.64427187123e-06 | 0.625 | FRAT2 FRAT1 AXIN2 AXIN1 GSK3B | Alzheimer 39 s disease and miRNA effects |
  WP:WP5124 | 4.64427187123e-06 | 0.625 | FRAT2 FRAT1 AXIN2 AXIN1 GSK3B | Alzheimer 39 s disease |
  REAC:R-HSA-201681 | 6.25196251181e-06 | 0.625 | FRAT2 FRAT1 AXIN2 AXIN1 GSK3B | TCF dependent signaling in response to WNT |
  WP:WP399 | 1.00491852039e-05 | 0.5 | FRAT1 AXIN2 AXIN1 GSK3B | Wnt signaling pathway and pluripotency |
  REAC:R-HSA-195253 | 1.28215875769e-05 | 0.5 | FRAT2 GSK3B AXIN1 FRAT1 | Degradation of beta-catenin by the destruction complex |
  WP:WP428 | 1.34339772658e-05 | 0.5 | FRAT2 GSK3B AXIN1 FRAT1 | Wnt signaling |
  GO:0030111 | 1.52540288285e-05 | 0.75 | GSKIP GSK3B GSK3A AXIN1 FRAT1 AXIN2 | regulation of Wnt signaling pathway |
  KEGG:05010 | 1.73213042512e-05 | 0.625 | FRAT2 FRAT1 AXIN2 AXIN1 GSK3B | Alzheimer disease |
  GO:1904886 | 2.15253635486e-05 | 0.375 | FRAT2 GSK3B FRAT1 | beta-catenin destruction complex disassembly |
  CORUM:7128 | 2.39226645298e-05 | 0.25 | GSKIP GSK3B | GSKIP-GSK3B-PRKAR2A complex |
  CORUM:7127 | 2.39226645298e-05 | 0.25 | GSKIP GSK3B | GSKIP-GSK3B-PRKAR2A complex |
  REAC:R-HSA-195721 | 3.79843925063e-05 | 0.625 | FRAT2 FRAT1 AXIN2 AXIN1 GSK3B | Signaling by WNT |
  KEGG:05022 | 4.60126953817e-05 | 0.625 | FRAT2 FRAT1 AXIN2 AXIN1 GSK3B | Pathways of neurodegeneration - multiple diseases |
  KEGG:05200 | 6.65080913942e-05 | 0.625 | FRAT2 FRAT1 AXIN2 AXIN1 GSK3B | Pathways in cancer |
  CORUM:3166 | 7.17483486175e-05 | 0.25 | GSK3B AXIN1 | AXIN1-APC-CTNNB1-GSK3B complex |
  CORUM:6352 | 7.17483486175e-05 | 0.25 | GSK3B AXIN1 | FoxM1-Axin-GSK3beta complex |
  CORUM:6353 | 7.17483486175e-05 | 0.25 | GSK3B AXIN1 | beta-Catenin destruction complex |
  CORUM:6963 | 7.17483486175e-05 | 0.25 | GSK3B AXIN1 | AXIN1-GID8-GSK3B complex |
  CORUM:7130 | 7.17483486175e-05 | 0.25 | GSKIP GSK3B | PRKAR2A-GSKIP-GSK3B-DNM1L complex |
  KEGG:05213 | 0.000116307002573 | 0.375 | AXIN2 AXIN1 GSK3B | Endometrial cancer |
  KEGG:05217 | 0.000137962042636 | 0.375 | AXIN2 AXIN1 GSK3B | Basal cell carcinoma |
  CORUM:4151 | 0.000143457417375 | 0.25 | GSK3B AXIN1 | TSC (TSC1, TSC2, AXIN, GSK3) complex |
  CORUM:2998 | 0.000143457417375 | 0.25 | GSK3B AXIN1 | Axin-PP2A A-PP2A C-GSK3-beta-beta-catenin complex |
  CORUM:7159 | 0.000143457417375 | 0.25 | GSK3B AXIN1 | TSC2-GSK3-AXIN-DVL complex |
  WP:WP4155 | 0.000283445979884 | 0.375 | AXIN2 AXIN1 GSK3B | Endometrial cancer |
  KEGG:05210 | 0.000397700652008 | 0.375 | AXIN2 AXIN1 GSK3B | Colorectal cancer |
  WP:WP4216 | 0.00046287066695 | 0.375 | AXIN2 AXIN1 GSK3B | Chromosomal and microsatellite instability in colorectal cancer |
  WP:WP2064 | 0.000625219299609 | 0.375 | AXIN2 AXIN1 GSK3B | Neural crest differentiation |
  KEGG:04550 | 0.00145234226842 | 0.375 | AXIN2 AXIN1 GSK3B | Signaling pathways regulating pluripotency of stem cells |
  WP:WP710 | 0.00159618281405 | 0.375 | FRAT1 GSK3B AXIN1 | DNA damage response only ATM dependent |
  KEGG:04934 | 0.00164110254365 | 0.375 | AXIN2 AXIN1 GSK3B | Cushing syndrome |
  GO:0007267 | 0.00164672421301 | 0.875 | GSKIP GSK3B GSK3A AXIN1 FRAT1 FRAT2 AXIN2 | cell-cell signaling |
  GO:0032436 | 0.00166453822603 | 0.5 | GSK3A AXIN2 AXIN1 GSK3B | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
  REAC:R-HSA-9683610 | 0.00200443712543 | 0.25 | GSK3A GSK3B | Maturation of nucleoprotein |
  WP:WP5087 | 0.00243275441359 | 0.5 | FRAT2 GSK3B AXIN1 FRAT1 | Pleural mesothelioma |
  KEGG:04390 | 0.00260993521755 | 0.375 | AXIN2 AXIN1 GSK3B | Hippo signaling pathway |
  WP:WP3664 | 0.00285973689486 | 0.25 | GSK3B AXIN1 | Regulation of Wnt B catenin signaling by small molecule compounds |
  GO:2000060 | 0.00349206859402 | 0.5 | GSK3A AXIN2 AXIN1 GSK3B | positive regulation of ubiquitin-dependent protein catabolic process |
  WP:WP3872 | 0.00407177869695 | 0.25 | GSK3A GSK3B | Regulation of apoptosis by parathyroid hormone related protein |
  REAC:R-HSA-9694631 | 0.00433819320746 | 0.25 | GSK3A GSK3B | Maturation of nucleoprotein |
  REAC:R-HSA-198323 | 0.00433819320746 | 0.25 | GSK3A GSK3B | AKT phosphorylates targets in the cytosol |
  GO:1901800 | 0.00461836161062 | 0.5 | GSK3A AXIN2 AXIN1 GSK3B | positive regulation of proteasomal protein catabolic process |
  GO:0090090 | 0.00504805624577 | 0.5 | GSK3A AXIN2 AXIN1 GSK3B | negative regulation of canonical Wnt signaling pathway |
  REAC:R-HSA-5467340 | 0.00505983974502 | 0.25 | GSK3B AXIN1 | AXIN missense mutants destabilize the destruction complex |
  REAC:R-HSA-5467348 | 0.00505983974502 | 0.25 | GSK3B AXIN1 | Truncations of AMER1 destabilize the destruction complex |
  REAC:R-HSA-4839748 | 0.00505983974502 | 0.25 | GSK3B AXIN1 | Signaling by AMER1 mutants |
  REAC:R-HSA-4839744 | 0.00505983974502 | 0.25 | GSK3B AXIN1 | Signaling by APC mutants |
  REAC:R-HSA-5467337 | 0.00505983974502 | 0.25 | GSK3B AXIN1 | APC truncation mutants have impaired AXIN binding |
  REAC:R-HSA-4839735 | 0.00505983974502 | 0.25 | GSK3B AXIN1 | Signaling by AXIN mutants |
  WP:WP2583 | 0.0054959559122 | 0.25 | GSK3A GSK3B | T cell receptor and co stimulatory signaling |
  REAC:R-HSA-5339716 | 0.00583667819665 | 0.25 | GSK3B AXIN1 | Signaling by GSK3beta mutants |
  REAC:R-HSA-5358747 | 0.00583667819665 | 0.25 | GSK3B AXIN1 | CTNNB1 S33 mutants aren't phosphorylated |
  REAC:R-HSA-5358749 | 0.00583667819665 | 0.25 | GSK3B AXIN1 | CTNNB1 S37 mutants aren't phosphorylated |
  REAC:R-HSA-5358751 | 0.00583667819665 | 0.25 | GSK3B AXIN1 | CTNNB1 S45 mutants aren't phosphorylated |
  REAC:R-HSA-5358752 | 0.00583667819665 | 0.25 | GSK3B AXIN1 | CTNNB1 T41 mutants aren't phosphorylated |
  REAC:R-HSA-4839743 | 0.00583667819665 | 0.25 | GSK3B AXIN1 | Signaling by CTNNB1 phospho-site mutants |
  WP:WP3658 | 0.00656300097601 | 0.25 | AXIN2 GSK3B | Wnt beta catenin signaling pathway in leukemia |
  GO:0046825 | 0.00824905178996 | 0.375 | FRAT2 GSK3B FRAT1 | regulation of protein export from nucleus |
  GO:1903052 | 0.00861152862574 | 0.5 | GSK3A AXIN2 AXIN1 GSK3B | positive regulation of proteolysis involved in protein catabolic process |
  GO:0032434 | 0.00964797417951 | 0.5 | GSK3A AXIN2 AXIN1 GSK3B | regulation of proteasomal ubiquitin-dependent protein catabolic process |
  WP:WP4844 | 0.0103268762936 | 0.25 | GSK3B AXIN1 | Influence of laminopathies on Wnt signaling |
  WP:WP127 | 0.0110360515043 | 0.25 | GSK3A GSK3B | IL 5 signaling pathway |
  GO:0030178 | 0.012426913615 | 0.5 | GSK3A AXIN2 AXIN1 GSK3B | negative regulation of Wnt signaling pathway |
  GO:2000077 | 0.0131096201623 | 0.25 | GSK3A GSK3B | negative regulation of type B pancreatic cell development |
  WP:WP500 | 0.0157805174951 | 0.25 | GSK3A GSK3B | Glycogen synthesis and degradation |
  REAC:R-HSA-5674400 | 0.0166306183768 | 0.25 | GSK3A GSK3B | Constitutive Signaling by AKT1 E17K in Cancer |
  REAC:R-HSA-9683701 | 0.0180115696713 | 0.25 | GSK3A GSK3B | Translation of Structural Proteins |
  KEGG:05165 | 0.0207258251199 | 0.375 | AXIN2 AXIN1 GSK3B | Human papillomavirus infection |
  GO:2000058 | 0.0229851818624 | 0.5 | GSK3A AXIN2 AXIN1 GSK3B | regulation of ubiquitin-dependent protein catabolic process |
  WP:WP4879 | 0.0255436500108 | 0.25 | GSK3B AXIN1 | Overlap between signal transduction pathways contributing to LMNA laminopathies |
  REAC:R-HSA-4791275 | 0.02920582473 | 0.25 | GSK3B AXIN1 | Signaling by WNT in cancer |
  REAC:R-HSA-162582 | 0.0324681032361 | 0.75 | GSK3B GSK3A AXIN1 FRAT2 FRAT1 AXIN2 | Signal Transduction |
  GO:0061136 | 0.0391228062182 | 0.5 | GSK3A AXIN2 AXIN1 GSK3B | regulation of proteasomal protein catabolic process |
  GO:2000466 | 0.0393180950424 | 0.25 | GSK3A GSK3B | negative regulation of glycogen (starch) synthase activity |
  WP:WP3680 | 0.0402976114103 | 0.25 | GSK3B AXIN1 | Physico chemical features and toxicity associated pathways |
  WP:WP5158 | 0.0402976114103 | 0.25 | GSK3A GSK3B | Urotensin II mediated signaling pathway |
  GO:0045732 | 0.0445000722229 | 0.5 | GSK3A AXIN2 AXIN1 GSK3B | positive regulation of protein catabolic process |
  HPA:0090162 | 0.0473766132884 | 0.875 | GSKIP RILPL2 GSK3B GSK3A AXIN1 FRAT1 AXIN2 | cerebellum; Purkinje cells[>=Medium] |
Edges
Protein 1 | Protein 2 | Score | ProteomeHD | Interface Overlap | Evidence |
---|---|---|---|---|---|
 GSK3A |  GSK3B | 1.0 | 0.196           |          | hein_WMM     bioplex3_HEK293     bioplex_WMM     bioplex3_WMM     youn_WMM     fraction     |
 GSK3A |  FRAT1 | 0.999 |            |
structurally_consistent (dimer)        
|
hein_WMM     bioplex3_HEK293     bioplex3_WMM     hein ()     bioplex3_HCT116     |
 FRAT2 |  RILPL2 | 0.999 |            |          | bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 GSKIP |  GSK3A | 0.999 | 0.09           |
structurally_consistent (dimer)        
|
bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 GSK3A |  AXIN1 | 0.998 | 0.23           |          | hein_WMM     bioplex3_HEK293     bioplex3_WMM     hein ()     bioplex3_HCT116     |
 GSK3A |  FRAT2 | 0.997 |            |
structurally_consistent (dimer)        
|
bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 GSKIP |  GSK3B | 0.997 | 0.136           |          | bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 AXIN2 |  GSK3A | 0.997 |            |          | bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 GSK3B |  FRAT2 | 0.996 |            |          | bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 GSK3B |  AXIN1 | 0.995 | 0.256           |          | hein_WMM     bioplex3_WMM     hein ()     gupta_WMM     |
 AXIN2 |  GSK3B | 0.992 |            |          | bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 GSK3B |  FRAT1 | 0.992 |            |          | hein_WMM     bioplex3_WMM     hein ()     |
 FRAT1 |  AXIN1 | 0.946 |            |          | bioplex3_WMM     WMM_only     |
 AXIN2 |  FRAT1 | 0.946 |            |          | bioplex3_WMM     WMM_only     |
 AXIN2 |  AXIN1 | 0.946 |            |          | bioplex3_WMM     WMM_only     |
 GSK3A |  RILPL2 | 0.874 | 0.106           |          | bioplex3_WMM     WMM_only     |
 GSKIP |  FRAT1 | 0.792 |            |
mutually_exclusive (P49840)        
|
bioplex3_WMM     WMM_only     |
 GSKIP |  AXIN1 | 0.757 | 0.212           |          | bioplex3_WMM     WMM_only     |
 GSK3B |  RILPL2 | 0.74 | 0.038           |          | bioplex3_WMM     WMM_only     |
 AXIN2 |  GSKIP | 0.466 |            |          | bioplex3_WMM     WMM_only     |
 AXIN2 |  FRAT2 | 0.274 |            |          | bioplex3_WMM     WMM_only     |
 AXIN1 |  FRAT2 | 0.25 |            |          | bioplex3_WMM     WMM_only     |
 FRAT1 |  FRAT2 | 0.135 |            |
mutually_exclusive (P49840)        
|
bioplex3_WMM     WMM_only     |
 GSKIP |  FRAT2 | 0.078 |            |
mutually_exclusive (P49840)        
|
bioplex3_WMM     WMM_only     |
Related Complexes